Related Experiment Videos
Mepartricin, a polyene active on both Trichomonas and Candida. Lack of mutagenic activity
Abstract:
Mepartricin, the methyl ester of partricin, is a new polyene antibiotic with antifungal and antiprotozoal activity. The antitrichomonas activity in vitro is comparable to that of metronidazole, the widely used drug recently demonstrated to possess mutagenic activity and thus to be used with caution in therapy. Clinical investigations have shown that mepartricin can be successfully used in the topic treatment of vaginal trichomoniasis and candidiasis. The mutagenic activity of mepartricin has been evaluated using the Ames' test and compared to that of metronidazole. No mutagenic activity was detected for mepartricin. The drug can thus be proposed as a safer and efficient alternative to metronidazole.
Insights
Mepartricin, a new antibiotic, shows antifungal and antiprotozoal activity comparable to metronidazole. Unlike metronidazole, mepartricin demonstrated no mutagenic activity in Ames
Area of Science:
- Microbiology
- Pharmacology
- Antimicrobial Agents
Background:
- Mepartricin is a novel polyene antibiotic derived from partricin.
- It exhibits antifungal and antiprotozoal properties.
- Metronidazole, a common treatment, has shown mutagenic activity, necessitating caution.
Purpose of the Study:
- To evaluate the antitrichomonas activity of mepartricin in vitro.
- To assess the mutagenic potential of mepartricin using the Ames' test.
- To compare mepartricin with metronidazole regarding efficacy and safety.
Main Methods:
- In vitro testing of antitrichomonas activity.
- Ames' test for mutagenicity assessment.
- Clinical investigation for topical treatment of vaginal infections.
Main Results:
- Mepartricin's in vitro antitrichomonas activity is comparable to metronidazole.
- No mutagenic activity was detected for mepartricin in the Ames' test.
- Clinical studies confirmed successful topical treatment of vaginal trichomoniasis and candidiasis.
Conclusions:
- Mepartricin is an effective agent against Trichomonas and Candida species.
- Mepartricin presents a safer alternative to metronidazole due to its lack of mutagenicity.
- The drug shows promise for topical treatment of vaginal infections.